<code id='15C8432D21'></code><style id='15C8432D21'></style>
    • <acronym id='15C8432D21'></acronym>
      <center id='15C8432D21'><center id='15C8432D21'><tfoot id='15C8432D21'></tfoot></center><abbr id='15C8432D21'><dir id='15C8432D21'><tfoot id='15C8432D21'></tfoot><noframes id='15C8432D21'>

    • <optgroup id='15C8432D21'><strike id='15C8432D21'><sup id='15C8432D21'></sup></strike><code id='15C8432D21'></code></optgroup>
        1. <b id='15C8432D21'><label id='15C8432D21'><select id='15C8432D21'><dt id='15C8432D21'><span id='15C8432D21'></span></dt></select></label></b><u id='15C8432D21'></u>
          <i id='15C8432D21'><strike id='15C8432D21'><tt id='15C8432D21'><pre id='15C8432D21'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:87
          Blue numbers and letter falling down a tunnel. -- health tech coverage from STAT
          Adobe

          A growing number of AI tools are being used to predict everything from sepsis to strokes, with the hope of accelerating the delivery of life-saving care. But over time, new research suggests, these predictive models can become a victim of their own success — sending their performance into a nosedive and generating inaccurate, potentially harmful results.

          “There is no accounting for this when your models are being tested,” said Akhil Vaid, an instructor of data-driven and digital medicine at the Icahn School of Medicine at Mount Sinai and author of the new research, published Monday in the Annals of Internal Medicine. “You can’t run validation studies, do external validation, run clinical trials — because all they’ll tell you is that the model works. And when it starts to work, that is when the problems will arise.”

          advertisement

          Vaid and his Mount Sinai colleagues simulated the deployment of two models that predicted a patient’s risk of dying and acute kidney injury within five days of entering the ICU. Their simulations assumed that the models did what they were supposed to — lower deaths and kidney injury by identifying patients for earlier intervention.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Medicare Advantage enrollment hits roughly 33.4 million
          Medicare Advantage enrollment hits roughly 33.4 million

          AdobeYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followingtheflowofmoneyinmed

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          In 'major milestone,' FDA approves first cell therapy for solid tumors

          MetastaticmelanomacellsJulioC.Valencia,/NCICenterforCancerResearchNearlyfourdecadesafteritsfirstconc